Ameriprise Financial Inc Tandem Diabetes Care Inc Transaction History

Ameriprise Financial Inc

$388 Billion
Q2 2025

A detailed history of Ameriprise Financial Inc transactions in Tandem Diabetes Care Inc stock. As of the latest transaction made, Ameriprise Financial Inc holds 419,037 shares of TNDM stock, worth $4.66 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

419,037

Previous 387,887 8.03%

Holding current value

$4.66 Million

Previous $7.43 Million 5.1%

% of portfolio

0.0%

Previous 0.0%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 14, 2025	BUY	$16.35 - $23.52 $509,302 - $732,648	31,150 Added 8.03%	419,037 $7.81 Million
Q1 2025 May 14, 2025	BUY	$17.89 - $37.53 $755,065 - $1.58 Million	42,206 Added 12.21%	387,887 $7.43 Million
Q4 2024 Feb 14, 2025	SELL	$27.34 - $41.78 $14.4 Million - $21.9 Million	-525,159 Reduced 60.3%	345,681 $12.5 Million
Q3 2024 Nov 14, 2024	SELL	$35.21 - $47.3 $21.5 Million - $28.8 Million	-609,934 Reduced 41.19%	870,840 $36.9 Million
Q2 2024 Aug 14, 2024	BUY	$30.43 - $53.43 $21 Million - $36.8 Million	688,746 Added 86.96%	1,480,774 $59.7 Million
Q1 2024 May 15, 2024	BUY	$22.09 - $35.41 $10.6 Million - $16.9 Million	478,474 Added 152.6%	792,028 $28 Million
Q4 2023 Feb 14, 2024	BUY	$14.28 - $31.03 $580,839 - $1.26 Million	40,675 Added 14.91%	313,554 $9.27 Million
Q3 2023 Nov 14, 2023	SELL	$19.33 - $36.22 $233,351 - $437,247	-12,072 Reduced 4.24%	272,879 $5.67 Million
Q2 2023 Aug 14, 2023	SELL	$24.18 - $42.46 $61,320 - $107,678	-2,536 Reduced 0.88%	284,951 $6.99 Million
Q1 2023 May 15, 2023	BUY	$35.86 - $46.5 $2.57 Million - $3.33 Million	71,579 Added 33.15%	287,487 $11.7 Million
Q4 2022 Feb 14, 2023	SELL	$35.49 - $56.15 $95,326 - $150,818	-2,686 Reduced 1.23%	215,908 $9.71 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $68.97 $371,391 - $585,348	8,487 Added 4.04%	218,594 $10.5 Million
Q2 2022 Aug 15, 2022	SELL	$53.22 - $123.09 $24.9 Million - $57.6 Million	-468,122 Reduced 69.02%	210,107 $12.4 Million
Q1 2022 May 16, 2022	BUY	$101.89 - $150.09 $49.6 Million - $73.1 Million	486,762 Added 254.23%	678,229 $78.9 Million
Q4 2021 Feb 14, 2022	BUY	$118.18 - $153.21 $2.4 Million - $3.12 Million	20,335 Added 11.88%	191,467 $29.1 Million
Q3 2021 Nov 15, 2021	BUY	$93.51 - $129.4 $8.14 Million - $11.3 Million	87,048 Added 103.53%	171,132 $20.4 Million
Q2 2021 Aug 16, 2021	SELL	$77.0 - $100.19 $12.5 Million - $16.3 Million	-162,385 Reduced 65.88%	84,084 $8.17 Million
Q1 2021 May 17, 2021	SELL	$81.28 - $104.34 $9.61 Million - $12.3 Million	-118,224 Reduced 32.42%	246,469 $21.8 Million
Q4 2020 Feb 12, 2021	SELL	$86.4 - $121.75 $138,585 - $195,287	-1,604 Reduced 0.44%	364,693 $34.9 Million
Q3 2020 Nov 16, 2020	BUY	$95.43 - $116.09 $1.8 Million - $2.19 Million	18,838 Added 5.42%	366,297 $40.4 Million
Q2 2020 Aug 14, 2020	BUY	$60.05 - $98.92 $1.3 Million - $2.14 Million	21,682 Added 6.66%	347,459 $34.4 Million
Q1 2020 May 15, 2020	BUY	$47.37 - $90.04 $4.58 Million - $8.7 Million	96,603 Added 42.15%	325,777 $21 Million
Q4 2019 Feb 14, 2020	BUY	$53.13 - $71.19 $9.8 Million - $13.1 Million	184,425 Added 412.13%	229,174 $13.6 Million
Q3 2019 Nov 14, 2019	SELL	$57.11 - $73.3 $401,997 - $515,958	-7,039 Reduced 13.59%	44,749 $2.64 Million
Q2 2019 Aug 14, 2019	BUY	$54.41 - $71.7 $572,828 - $754,857	10,528 Added 25.52%	51,788 $3.34 Million
Q1 2019 May 15, 2019	SELL	$32.25 - $73.56 $8.98 Million - $20.5 Million	-278,464 Reduced 87.1%	41,260 $2.62 Million
Q4 2018 Feb 14, 2019	BUY	$28.45 - $40.65 $826,415 - $1.18 Million	29,048 Added 9.99%	319,724 $12.1 Million
Q3 2018 Nov 14, 2018	SELL	$21.39 - $51.17 $4.08 Million - $9.76 Million	-190,789 Reduced 39.63%	290,676 $12.5 Million
Q2 2018 Aug 14, 2018	BUY	$4.9 - $23.64 $2.36 Million - $11.4 Million	481,465 New	481,465 $10.6 Million

Others Institutions Holding TNDM

# of Institutions

300

Shares Held

81M

Call Options Held

2.87M

Put Options Held

134K

View Full List

About TANDEM DIABETES CARE INC

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $713M
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

More about TNDM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ameriprise Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ameriprise Financial Inc with notifications on news.

Account

Ameriprise Financial Inc Tandem Diabetes Care Inc Transaction History